A
TLANTA — This weekend’s American Society of Hematology (ASH) annual meeting was bit like playing in a Brooklyn children’s soccer tournament: Everyone got a congratulatory trophy just for showing up.
Well … not everyone. To extend the tortured P.C. soccer metaphor, Syros Pharmaceuticals (SYRS) was ejected with a red card. Unsportsmanlike conduct.
Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
